SeekGene, a biotechnology company focused on "driving the development and democratization of innovative single-cell technologies", announced it has officially joined the Human Cell Atlas (HCA) Commercial Discount Program, providing eligible consortium members with exclusive commercial discounts on its single-cell platforms and assays to support large-scale cell atlas research worldwide.
The Human Cell Atlas is an international initiative to map every human cell type as a foundation for understanding health and disease. By participating in the program, SeekGene aims to lower cost and technical barriers to integrated single-cell analysis, enabling more research teams to generate consistent, high-quality multi-omics datasets at scale.
The Human Cell Atlas consortium welcomes the participation of technology developers like SeekGene. Access to advanced and accessible single-cell multi-omics tools is crucial for our global research community to build comprehensive reference maps. "
John Randell, Executive Director of the HCA
Supporting Integrated Single-Cell Multi-Omics Research
HCA consortium members will have access to exclusive commercial discounts on SeekGene's cutting-edge single-cell products, covering integrated solutions from sample preparation to data analysis. This initiative aims to lower the barrier to applying single-cell multi-omics technologies, enabling more research teams to efficiently conduct large-scale cell atlas mapping projects.
Recently launched, the SeekOne™ DD Single-Cell DNA Methylation + RNA Multi-Omics solution enables simultaneous high-throughput profiling of RNA transcriptomes, immune repertoires (TCR/BCR), and genome-wide DNA methylation (5mC/5hmC) from the same cell, will provide a new dimension for Human Cell Atlas construction. By linking transcriptional and epigenetic information, the platform helps researchers better characterize cellular identity, regulatory states, and disease mechanisms. The system is designed for scalable studies and is compatible with fresh or frozen tissues as well as single-cell and single-nucleus workflows, making it well suited for population-scale atlas initiatives.
Furthermore, SeekGene offers a complete portfolio of solutions covering diverse research scenarios:
SeekOneTM DD Single-Cell Multiome ATAC + RNA Kit: utilizes innovative universal bead technology to simultaneously capture RNA and chromatin accessibility (ATAC) information from the same cell, delivering both high throughput and experimental stability.
SeekOne™ DD Single Cell Full-length RNA Sequence Transcriptome-seq Kit: Enables unbiased capture of the full transcriptome (including both coding and non-coding RNA), utilizing innovative blocker technology to reduce rRNA and mitochondrial contamination. Ideal for research on viral infection, cell development, and target screening.
SeekSpace™ Single Cell Spatial Transcriptome-seq Kit: Combines the preservation of cellular spatial information with the acquisition of high-purity single-cell data, delivering high-quality data crucial for precise spatial mapping of cells in HCA tissue and organ studies.
SeekOne™ DD Single-Cell 3'/5' Transcriptome-seq Kits: Serve as fundamental tools for basic single-cell gene expression analysis, meeting a wide range of basic research needs.
To empower researchers to effectively utilize these solutions, SeekGene provides a full suite of dedicated instruments and analysis software, including cell counters and tissue dissociation kits, offering comprehensive support for the entire experimental workflow.
"The Human Cell Atlas is a critical collaborative project in global life sciences, requiring synergy between the research community and industry," said ZongWen Li, CEO of SeekGene, "By joining the HCA program, we hope to make advanced single-cell multi-omics more accessible to researchers worldwide. Our goal is to democratize these technologies and support the global effort to build high-resolution maps of human biology."
New Epigenetic Catalog Helps Explain Individual Differences in Immune Responses